4. Avandia - Top 10 Warnings and Recalls
Drug: Avandia
2006 sales: $3.4 billion
Manufacturer: GlaxoSmithKline
Safety concern: “black box;” heart failure, heart attack
Related Articles:
> New Avandia warning 'a muddle'. Report
> Avandia warning, comeback imminent? Report
> Avandia cleared FDA by one vote. Report
> Avandia, Actos don't boost death risk. Report
> FDA adds to drumbeat of bad news for Avandia. Report
> Expert committee says Avandia should stay. Report
> FDA expert wants Avandia withdrawn. Report
> Docs shunning Avandia in wake of safety study. Report
> Avandia risks exposed under deal to post data. Report
Comments
Post new comment
Paid Research Reports
- Stakeholder Opinions: Vaccines in Emerging Markets (Asia) - Opportunities in China, India, South Korea and Taiwan
- Big Pharma Performance Before, During and Beyond the Global Recession
- Optimizing Lifecycle Management: Maximizing commercial lifespan through label expansion and combination products
- The CRO Market Outlook: Emerging markets, leading players and future trends
- Pharmaceutical Sales Force Effectiveness Strategies
- Commercial Insight: Influenza Vaccines and Antivirals - The pandemic's long-term impact
